Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| SQZ Biotechnologies Company | SQZ | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.435 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.435 | 0.435 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.25 - 0.6899 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.435 | USD |
SQZ Biotechnologies Company Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 12.68M | 29.49M | - | 21.48M | -79.46M | -2.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SQZ Biotechnologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/23/2024 | 15:31 | Edgar (US Regulatory) | Form DEFM14A - Definitive proxy statement relating to merger.. |
| 12/22/2023 | 16:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/08/2023 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 9/15/2023 | 08:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/25/2023 | 06:34 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/07/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/03/2023 | 12:53 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/15/2023 | 15:30 | Business Wire | SQZ Biotechnologies to Consolidate Shares with 1-for-10.. |
| 5/10/2023 | 15:45 | Business Wire | SQZ Biotechnologies Reports First Quarter 2023 Financial.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SQZ Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.62 | 0.6899 | 0.25 | 0.4349897 | 702,892 | -0.185 | -29.84% |
| 3 Years | 12.77 | 16.17 | 0.25 | 3.99 | 230,991 | -12.34 | -96.59% |
| 5 Years | 14.00 | 36.49 | 0.25 | 6.05 | 219,023 | -13.57 | -96.89% |
SQZ Biotechnologies Description
| SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays. |
